Pelliciari, D. H. S., Reis, C. R. A. and Bordini, C. A. (2024) “Should anti-CGRP monoclonal antibodies always be the drug of first choice for migraine prophylaxis in Brazil? - a pharmacoeconomic study”, Headache Medicine, 15(3), pp. 170–174. doi: 10.48208/HeadacheMed.2024.34.